CONTRAST ENHANCEMENT IN MAGNETIC RESONANCE IMAGING
Clinical trials for CONTRAST ENHANCEMENT IN MAGNETIC RESONANCE IMAGING explained in plain language.
Never miss a new study
Get alerted when new CONTRAST ENHANCEMENT IN MAGNETIC RESONANCE IMAGING trials appear
Sign up with your email to follow new studies for CONTRAST ENHANCEMENT IN MAGNETIC RESONANCE IMAGING, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New MRI dye could make scans safer for kids
Diagnosis CompletedThis study tests a new contrast agent called gadoquatrane in children from birth to under 18 years old who need a contrast-enhanced MRI. The goal is to see how the drug moves through the body and check its safety. Each child gets a single injection during their MRI, and researche…
Matched conditions: CONTRAST ENHANCEMENT IN MAGNETIC RESONANCE IMAGING
Phase: PHASE3 • Sponsor: Bayer • Aim: Diagnosis
Last updated Jul 19, 2026 00:00 UTC
-
New MRI dye could mean less gadolinium for patients
Diagnosis CompletedThis study tested a new contrast agent called gadoquatrane for MRI scans of the body (excluding the brain and spine). The goal was to see if using a lower dose of gadolinium could still produce clear images. 404 adults with known or suspected health issues received two MRI scans:…
Matched conditions: CONTRAST ENHANCEMENT IN MAGNETIC RESONANCE IMAGING
Phase: PHASE3 • Sponsor: Bayer • Aim: Diagnosis
Last updated Jun 27, 2026 08:05 UTC